Axon (AXON) Tops Q2 EPS by 5c; offers outlook

Axon (NASDAQ: AXON) reported Q2 EPS of $1.88, $0.05 better than the analyst estimate of $1.83. Revenue for the quarter came in at $904.3 million versus the consensus estimate of $876.46 million.

OUTLOOK

2026 Revenue: Axon expects full-year 2026 revenue growth in a range of 32% to 34%, an increase from 30% to 32% previously. Our increased revenue guidance is supported by our continued execution against $15.1 billion in Future Contracted Bookings, and an expanding pipeline that supports our expectation for greater than 30% growth in five-year normalized bookings year over year for 2026.

For earnings history and earnings-related data on Axon (AXON) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Nuvectis Pharma (NVCT) files $200M mixed shelf
• Cytek faces $56M damages award in Beckman Coulter patent case